MedPath

Effect of Citalopram on Endometriosis

Phase 3
Recruiting
Conditions
Endometriosis.
Endometriosis
Registration Number
IRCT20180211038692N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Symptomatic patients with endometriosis under medical treatment
age between 18 till 45
no desire for pregnancy

Exclusion Criteria

pregnancy
lactation
abnormal findings against endometriosis
indication for surgery
drug intolerance
SSRIs contraindications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
???????? ??????. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dysmenorrhea. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dyschezia. Timepoint: Visual analogous scale. Method of measurement: Visual analogous scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath